1.
Mult Scler Relat Disord
; 24: 38-41, 2018 Aug.
Article
in English
| MEDLINE
| ID: mdl-29885597
ABSTRACT
We report the case of a patient who died from the rare complication of Listeriosis in the immediate phase following alemtuzumab administration one month after discontinuing dimethyl fumarate (DMF). There is considerable overlap with typical post-infusion symptoms therefore high surveillance and low threshold for empirical or possible prophylactic antibiotic therapy is advocated.